Minerva Neurosciences, Inc. (NERV)

4.06 +0.16 (+4.10%) USD  |  NASDAQ  |  Jan 23, 14:53
More

Minerva Neurosciences Proceeds from Stock Option Exercised (Annual)

Proceeds from Stock Option Exercised (Annual) Chart

View Proceeds from Stock Option Exercised (Annual) for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Annual) Benchmarks

View Proceeds from Stock Option Exercised (Annual) Benchmarks
Start Trial
iBio, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade